# DESCOVY

NDC: 61958-2002
Generic name: emtricitabine and tenofovir alafenamide
Labeler / Manufacturer: Gilead Sciences, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20160404

FDA application: NDA208215

## Active ingredients

- EMTRICITABINE: 200 mg/1
- TENOFOVIR ALAFENAMIDE FUMARATE: 25 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"61958-2002"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=61958-2002
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=06f66e98-e6ee-4538-9506-6c1282cc14c1